The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; PharmaMar; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; PharmaMar; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Weekly selinexor, bortezomib, and dexamethasone (SVd) versus twice weekly bortezomib and dexamethasone (Vd) in patients with multiple myeloma (MM) after one to three prior therapies: Initial results of the phase III BOSTON study.
 
Meletios A. Dimopoulos
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda
 
Sosana Delimpasi
Speakers' Bureau - Amgen; Janssen
 
Maryana Simonova
No Relationships to Disclose
 
Ivan Spicka
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Novartis; Sanofi; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Novartis; Sanofi; Takeda
 
Ludek Pour
No Relationships to Disclose
 
Iryna Kryachok
Consulting or Advisory Role - Janssen; Takeda
Research Funding - Abbvie; Acerta Pharma; Bayer; Debiopharm Group; Janssen; Karyopharm Therapeutics; MSD
Expert Testimony - Janssen; Takeda
Travel, Accommodations, Expenses - Abbvie; MSD; Roche; Takeda
 
Maria Gavriatopoulou
Honoraria - Amgen; Genesis Cancer Care; Janssen-Cilag; Karyopharm Therapeutics; Takeda
 
Halyna Pylypenko
No Relationships to Disclose
 
Holger W Auner
Consulting or Advisory Role - Amgen; Karyopharm Therapeutics; Takeda
Speakers' Bureau - Janssen
Research Funding - Amgen
Travel, Accommodations, Expenses - Apollo Therapeutics; Takeda
 
Xavier Leleu
No Relationships to Disclose
 
Vadim Doronin
No Relationships to Disclose
 
Polina Kaplan
No Relationships to Disclose
 
Roman Hajek
No Relationships to Disclose
 
Benjamin Reuben
No Relationships to Disclose
 
Tuphan Kanti Dolai
No Relationships to Disclose
 
Dinesh Kumar Sinha
Research Funding - Excel Life Sciences
 
Melina Arazy
Employment - Karyopharm Therapeutics
Leadership - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Other Relationship - Karyopharm Therapeutics
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst)
 
Sebastian Grosicki
No Relationships to Disclose